These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9166965)

  • 21. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.
    Lowe GD; Rumley A; Woodward M; Morrison CE; Philippou H; Lane DA; Tunstall-Pedoe H
    Br J Haematol; 1997 Jun; 97(4):775-84. PubMed ID: 9217176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory screening of thrombophilia testing requisitions for adequacy/appropriateness and reduced abnormal results.
    Ahluwalia J; Sharma P; Das R
    Int J Lab Hematol; 2012 Dec; 34(6):661-2. PubMed ID: 22709246
    [No Abstract]   [Full Text] [Related]  

  • 23. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal activities of protein C, protein S and antithrombin III in young patients with retinal vein occlusion.
    Guareschi G; Viganò D'Angelo S; Foresti V; Bandello F; D'Angelo A
    Haematologica; 1990; 75(5):483-4. PubMed ID: 2151449
    [No Abstract]   [Full Text] [Related]  

  • 25. [Expanded blood coagulation screening--a necessity in diagnosis and therapy of thrombosis?].
    Wozniak G; Montag H; Alemany J
    Vasa Suppl; 1992; 35():92-3. PubMed ID: 1481078
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of antithrombin III, protein C and protein S in acute mesenteric ischemia patients.
    Ağaoğlu N; Türkyilmaz S; Ozlü C; Arslan MK; Colak E
    Acta Chir Belg; 2004 Apr; 104(2):184-6. PubMed ID: 15154576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.
    Palareti G; Legnani C; Frascaro M; Flamigni C; Gammi L; Gola G; Fuschini G; Coccheri S
    Contraception; 1999 May; 59(5):293-9. PubMed ID: 10494482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis.
    Vaziri ND; Shah GM; Winer RL; Gonzales E; Patel B; Alikhani S; Nguyen QX; Yamamoto J
    Thromb Res; 1989 Jan; 53(2):173-80. PubMed ID: 2522249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate.
    Franzoi M; Simioni P; Luni S; Zerbinati P; Girolami A; Zanardo V
    Thromb Res; 2002 Jan; 105(1):15-8. PubMed ID: 11864701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
    Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein C deficiency and stroke in early life.
    Kennedy CR; Warner G; Kai M; Chisholm M
    Dev Med Child Neurol; 1995 Aug; 37(8):723-30. PubMed ID: 7672469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins.
    High KA
    Arch Pathol Lab Med; 1988 Jan; 112(1):28-36. PubMed ID: 2962557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological variation in analyte concentrations in urine of apparently healthy men and women.
    Gowans EM; Fraser CG
    Clin Chem; 1987 Jun; 33(6):847-50. PubMed ID: 3594833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced thrombin generation in normal and hypertensive pregnancy.
    de Boer K; ten Cate JW; Sturk A; Borm JJ; Treffers PE
    Am J Obstet Gynecol; 1989 Jan; 160(1):95-100. PubMed ID: 2521425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [May (must?) in a for recurrent thrombophlebitis [with normal AT III/ protein C+S] fully "marcumarized" patient (with [otherwise?] negative contraindications) with acute posterior wall infarct (15 min "old") a brief lysis therapy be instituted?].
    Seitz R
    Internist (Berl); 1995 Dec; 36(12):1202. PubMed ID: 8567228
    [No Abstract]   [Full Text] [Related]  

  • 37. Inappropriate use of protein C, protein S, and antithrombin testing for hereditary thrombophilia screening: an experience from a large university hospital.
    Tientadakul P; Chinthammitr Y; Sanpakit K; Wongwanit C; Nilanont Y
    Int J Lab Hematol; 2011 Dec; 33(6):593-600. PubMed ID: 21569220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.
    Zhu T; Ding Q; Bai X; Wang X; Kaguelidou F; Alberti C; Wei X; Hua B; Yang R; Wang X; Wang Z; Ruan C; Schlegel N; Zhao Y
    Haematologica; 2011 Jul; 96(7):1033-40. PubMed ID: 21486865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
    Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
    Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.